Prior to NP's termination, the bashers (former 13Der's, shorts, etc) were focusing on NP and the financials. Now it's mostly the financials. The TNBC news was great to know, but it's too far out to move the financials due to the small number of patients. I would prefer they hold off on any PRs unless it's to announce something that will "immediately" improve the financials. Otherwise, any positive PRs that tell us good results may move the sp slightly up but only to be bashed back down due to the uncertainty that surrounds the financials.

Quote:

---

TNBC was a major update and 300 mg open label NASh imo was still huge. Problem is why can’t we see it.

---